Merck Agrees To Supply US With Experimental COVID-19 Treatment

Reuters (12/23, Banerjee) reported, “Merck & Co said on Wednesday it would supply 60,000-100,000 doses of its experimental COVID-19 treatment to the U.S. government for up to about $356 million.” This “agreement will help support advanced development and...